These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28760652)

  • 1. Serum amyloid A enrichment impairs the anti-inflammatory ability of HDL from diabetic nephropathy patients.
    Mao JY; Sun JT; Yang K; Shen WF; Lu L; Zhang RY; Tong X; Liu Y
    J Diabetes Complications; 2017 Oct; 31(10):1538-1543. PubMed ID: 28760652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of inflammatory mediators and proinflammatory monocytes in patients with type I diabetes mellitus and nephropathy.
    Kolseth IB; Reine TM; Parker K; Sudworth A; Witczak BJ; Jenssen TG; Kolset SO
    J Diabetes Complications; 2017 Jan; 31(1):245-252. PubMed ID: 27452162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein loses its anti-inflammatory capacity by accumulation of pro-inflammatory-serum amyloid A.
    Tölle M; Huang T; Schuchardt M; Jankowski V; Prüfer N; Jankowski J; Tietge UJ; Zidek W; van der Giet M
    Cardiovasc Res; 2012 Apr; 94(1):154-62. PubMed ID: 22328092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications.
    Li Y; Zhao M; He D; Zhao X; Zhang W; Wei L; Huang E; Ji L; Zhang M; Willard B; Fu Z; Wang L; Pan B; Zheng L; Ji L
    Lipids Health Dis; 2016 Apr; 15():76. PubMed ID: 27074994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-inflammatory function of HDL is impaired in type 2 diabetes: role of hyperglycemia, paraoxonase-1 and low grade inflammation.
    Ebtehaj S; Gruppen EG; Parvizi M; Tietge UJF; Dullaart RPF
    Cardiovasc Diabetol; 2017 Oct; 16(1):132. PubMed ID: 29025405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.
    Zewinger S; Drechsler C; Kleber ME; Dressel A; Riffel J; Triem S; Lehmann M; Kopecky C; Säemann MD; Lepper PM; Silbernagel G; Scharnagl H; Ritsch A; Thorand B; de las Heras Gala T; Wagenpfeil S; Koenig W; Peters A; Laufs U; Wanner C; Fliser D; Speer T; März W
    Eur Heart J; 2015 Nov; 36(43):3007-16. PubMed ID: 26248570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of advanced glycation end products and chronic kidney disease with macroangiopathy in type 2 diabetes.
    Rigalleau V; Cougnard-Gregoire A; Nov S; Gonzalez C; Maury E; Lorrain S; Gin H; Barberger-Gateau P
    J Diabetes Complications; 2015 Mar; 29(2):270-4. PubMed ID: 25468311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated peptides are associated with the variability of endothelial dysfunction in the cerebral vessels and the kidney in type 2 diabetes mellitus patients: a cross-sectional study.
    Petrica L; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Vlad D; Popescu R; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Jianu DC
    J Diabetes Complications; 2015 Mar; 29(2):230-7. PubMed ID: 25511877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of renal involvement on peripheral blood mononuclear cell expression behaviour of tumour necrosis factor-alpha and interleukin-6 in type 2 diabetic patients.
    Navarro JF; Mora C; Gómez M; Muros M; López-Aguilar C; García J
    Nephrol Dial Transplant; 2008 Mar; 23(3):919-26. PubMed ID: 17911088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement.
    Li L; Zhang X; Li Z; Zhang R; Guo R; Yin Q; Yang L; Yue R; Su B; Huang S; Xu H; He C; Liu F
    J Diabetes Complications; 2017 Jan; 31(1):114-121. PubMed ID: 27838100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctional high-density lipoproteins in children with chronic kidney disease.
    Kaseda R; Jabs K; Hunley TE; Jones D; Bian A; Allen RM; Vickers KC; Yancey PG; Linton MF; Fazio S; Kon V
    Metabolism; 2015 Feb; 64(2):263-73. PubMed ID: 25467845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C; Genser B; Drechsler C; Krane V; Kaltenecker CC; Hengstschläger M; März W; Wanner C; Säemann MD; Weichhart T
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):224-31. PubMed ID: 25424990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept.
    Fogelfeld L; Hart P; Miernik J; Ko J; Calvin D; Tahsin B; Adhami A; Mehrotra R; Fogg L
    J Diabetes Complications; 2017 Mar; 31(3):624-630. PubMed ID: 28041817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial.
    Mafi A; Namazi G; Soleimani A; Bahmani F; Aghadavod E; Asemi Z
    Food Funct; 2018 Sep; 9(9):4763-4770. PubMed ID: 30113051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephropathy, but not Angiographically Proven Retinopathy, is Associated with Neutrophil to Lymphocyte Ratio in Patients with Type 2 Diabetes.
    Ciray H; Aksoy AH; Ulu N; Cizmecioglu A; Gaipov A; Solak Y
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):267-71. PubMed ID: 25853704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between vitamin D status and vascular complications in patients with type 2 diabetes mellitus.
    Jung CH; Kim KJ; Kim BY; Kim CH; Kang SK; Mok JO
    Nutr Res; 2016 Feb; 36(2):117-24. PubMed ID: 26826427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of decreased serum complement 3 in patients with diabetic nephropathy.
    Zhang J; Wang Y; Zhang R; Li H; Han Q; Guo R; Wang T; Li L; Liu F
    Acta Diabetol; 2018 Jan; 55(1):31-39. PubMed ID: 29043511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.